Snowball logo
logo
6003

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

600332 SHG
¥21.51+¥0.02  (0.09%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
69,014.170,788.275,515.474,992.877,445.178,460.2
COGS
55,824.757,547.761,372.962,518.165,686.165,905.2
Gross Profit
13,189.313,240.514,142.512,474.711,75912,555
Operating Expenses & Income
Operating Income
4,7865,074.45,120.93,596.43,101.93,343.6
Total Operating Expenses
8,403.38,166.19,021.68,878.38,657.127,761
R&D Expenses
874.7819.5782.1763.8607.6665.7
Selling General & Admin Expenses
1,978.72,166.92,367.52,363.23,138.77,687.4
Earnings from Continuing Operations
Interest Expense
(439.5)(453.2)(470.1)(439.4)(427)(403.3)
Interest Income
563.9626.8486.3404.3141.988.66
Income Tax Expense
754.1789.9851.2606.8629.2255.7
Net Income
Net Income
3,719.93,966.54,055.72,835.52,983.12,945.6
Supplemental
EBIT
3,970.14,487.14,796.53,473.93,101.9-
EBITDA
4,3905,001.65,461.84,068.34,057.7-
In millions of CNY, except % and values per 1 share